SOURCE: Press Ventures

October 28, 2013 17:00 ET

Press Ventures Enhances Consumer Experience Through PayPal

WARSAW, POLAND--(Marketwired - Oct 28, 2013) -  Press Ventures Inc. (OTCQB: PVEN) ("Press Ventures" or the "Company") and its wholly-owned Polish subsidiary Biosafety Systems, Inc. Sp z o.o. ("BSI"), are pleased to announce that it has completed the merchant account administration process with PayPal. The BSI PayPal merchant account is intended to be utilized to complete financial transactions with potential customers purchasing various products and services related to the Company's patented Cedar Leaf Oil Diffusion ("CLO-D") technology.

"PayPal is one of the few globally recognized leaders in personal electronic commerce transactions," stated Mr. Edward Denkiewicz, Press Ventures CEO. "Having PayPal as an option of choice for our customers will enhance the selling proposition for our Company by enabling individual transactions to occur with the utmost efficiency and security."

PayPal is the world largest online payment, e-commerce, and money transfer business. PayPal operates in over 190 markets and manages more than 232 million accounts, more than 100 million of them active. PayPal allows customers to send, receive, and hold funds in 26 currencies worldwide.

Additionally, in an effort to give its shareholders and other interested parties access to the most timely and accurate information regarding the Company, Press Ventures and BSI will be providing updates exclusively via news releases, securities filings, and through social media tools, such as Twitter and Facebook. For additional information about CLO-D technology and Press Ventures, please visit www.biosafetysystemsinc.com

About Press Ventures
Press Ventures holds the worldwide rights to the patented Cedar Leaf Oil Diffusion ("CLO-D") technology for the use of natural products to kill bacteria, mold, and viruses in buildings. The patented CLO-D technology has been shown to be capable of killing many deadly bacterial and viral substances such as anthrax and H1N1 in buildings while they are still occupied. The CLO-D technology has been laboratory and field tested and the Company believes that use of the technology can provide a marked improvement in air quality and eliminate many of the most dangerous airborne bacteria, viruses, and pollutants. For additional information about CLO-D technology and Press Ventures, please visit www.biosafetysystemsinc.com

Notice Regarding Forward-Looking Statements
This news release contains "forward-looking statements" as that term is defined in Section 27(a) of the Securities Act of 1933, as amended, and Section 21(e) of the Securities Exchange Act of 1934, as amended. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, potential revenue or profits generated by CLO-D product sales. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products or technologies and operating as a development stage company, our ability to retain important members of our management team and attract other qualified personnel, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, our ability to develop and commercialize products based on our technology platform, and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.

Contact Information